Skip to main content
Clinical Trials/TCTR20220122001
TCTR20220122001
Completed
Phase 2

The Effect of supplemental Oxygen on 6-minute Walk Test in Chronic Obstructive Pulmonary Disease (COPD) Patients

Isfahan University of Medical Sciences0 sites100 target enrollmentJanuary 22, 2022

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Chronic obstructive pulmonary disease
Sponsor
Isfahan University of Medical Sciences
Enrollment
100
Status
Completed
Last Updated
last year

Overview

Brief Summary

supplemental oxygen used in the time of exercise testing or 6MWT has a considerable positive effect in cases with COPD.

Registry
who.int
Start Date
January 22, 2022
End Date
January 6, 2022
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • (I) definitive diagnosis of moderate to severe COPD, (II) weeks without exacerbations), (III) lack of acute coronary syndrome, (IV) FEV 1 /FVC ratio of less than 0\.7, and 50 %\< FEV\<80% (stage 2\) and 30 %\< FEV\<50% (stage 3\), (V) a cigarettes smoking history of more than 10 pack\-years, and (VI) ability to walk.

Exclusion Criteria

  • 1\-Patients with complications during the test were excluded from the study.
  • 2\- Patients who didn't have informed consent.
  • 3\- patients with other serious health problems.

Outcomes

Primary Outcomes

Not specified

Similar Trials